Anticoagulation

Leiden, The Netherlands, August 20, 2026 VarmX has enrolled the first participant in its global Phase 3 EquilibriX-S trial,...

PONTE VEDRA, Fla., June 24, 2026 Cadrenal Therapeutics, Inc. announced that late-breaking clinical data from its Phase 2 study...

Ponte Vedra, Florida | June 18, 2026 Cadrenal Therapeutics, Inc. announced plans to submit a request to the U.S....